Quick Takeaways
- Alexandra Wood (Canada) Inc. filed SCHEDULE 13G for Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO).
- Disclosed ownership: 9.5%.
- Date of event: 13 Dec 2024.
Alexandra Wood (Canada) Inc. - 13 Dec 2024 SCHEDULE 13G Report for Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO)
- Filing Manager
- Alexandra Wood (Canada) Inc.
- Reporting Manager
- Alexandra Wood (Canada) Inc.
- Symbol
- CHRO
- Shares outstanding
- 6,025,047 shares
- Disclosed Ownership
- 574,187 shares
- Ownership
- 9.5%
- Form type
- SCHEDULE 13G
- Filing time
- 15 Jan 2025, 17:27:29 UTC
- Date of event
- 13 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Alexandra Wood (Canada) Inc. disclosed 9.5% ownership in Channel Therapeutics Corp Common Stock, par value $0.0001 per share (CHRO) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Jan 2025, 17:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alexandra Wood (Canada) Inc. | 9.5% | 574,187 | 574,187 | 0 | /s/ Marc J. Ross | Marc J. Ross, Esq. As Attorney-In-Fact |